Safety Study of RTL1000 (Recombinant T Cell Recep...
Link for RTL1000 have a look.
Artielle Immunotherapeutics Initiates Clinical Trials For Multiple ...
Micromet/TRACON/D93, Arielle Immuno/RTL1000, Arxxant
RTL1000
Promising MS Drug Trial Testing in Seattle
Multiple Sclerosis drug's trials are just a start
Drug's trials are just a start
Una nueva terapia para la EM emerge de la investigación
| 4 Aug 2007 by Bill Safety Study of RTL1000 (Recombinant T Cell Receptor Ligand) in Subjects With Multiple Sclerosis This study is currently recruiting patients. Verified by Artielle ImmunoTherapeutics March 2007 Sponsored by: Artielle ImmunoTherapeutics ... Multiple Sclerosis News Blog - http://multiplesclerosisnewsblog.blogspot.com/ [ More results from Multiple Sclerosis News Blog ] |
| 4 Aug 2007 by personallog! Here it is!!!!! Hmmmm good for mice so far! Joy!(Sarcasm doesn't come over does it?) Only a 10 year wait eh! Msn has given me a 2 gig storage space for my emails.....Just after I had cleared the inbox too. Admin has never been my strong ... ms not just a diary. - http://davesmsblog.blogspot.com/ |
| 24 May 2007 by Cary J. Polevoy Artielle ImmunoTherapeutics, Inc. today announced that the Company has initiated a Phase I clinical trial to evaluate its novel drug candidate, RTL1000, for the treatment of multiple sclerosis (MS). RTL1000 is a novel protein drug with ... MS Toolkit - http://ms-toolkit.blogspot.com/ |
| 22 Mar 2007 by Forrest The clinical trial is designed to assess the safety and pharmacokinetic properties of RTL1000. The study will be conducted at research centers located in New Haven, Connecticut; Indianapolis, Indiana; Kansas City, Kansas; Baltimore, ... Ophthalmic News - http://ophthalert.blogspot.com/index.html |
| 27 Jul 2007 by orange sunrise OHSU Oregon Health & Science University MS . Orange Seed - http://orangeribbon.blog99.fc2.com/ |
| 3 Aug 2007 OHSU professor of neurology Arthur Vandenbark developed the drug RTL1000. In earlier stages of research, his team took mice paralyzed by MS and gave them RTL1000. The results were nothing short of amazing. ... Stu's Views and MS Related News - http://msviewsandrelatednews.com/blog5/ |
| 20 Jul 2007 by squiffy2 RTL1000 was developed by scientists working at OHSU and the Portland Veterans Affairs Medical Center. In experiments involving laboratory mice, “it was the best thing I’d seen in 35 years,” said Arthur Vandenbark, OHSU neurology ... BrainTalk Communities - http://brain.hastypastry.net/forums |
| 20 Jul 2007 In late May, physicians at OHSU injected the first Pacific Northwest patient with an experimental drug called RTL1000. The patient, Anne Foster of Montesano, Wash., so far has reported no adverse reaction to the drug – a positive ... MSRC Latest MS Research News - http://feeds.rapidfeeds.com/?fid4ct=3070 [ More results from MSRC Latest MS Research News ] |
| 29 Jul 2007 by Carles Riquelme i Felip El RTL1000 ha sido desarrollado por científicos que trabajan en el OHSU y en el Portland Veterans Affairs Medical Center. En experimentos con ratones, Arthur Vandenbark, profesor de neurología del OHSU, y jefe de investigación del ... GRUPO INDEPENDIENTE DE ESCLEROSIS MÚLTIPLE... - http://gidem.blogspot.com/ |
| 23 Jun 2007 by Kalimbo_Mwero RTL 50mm f1.8 ... +++Retro*Spectrum+++ - http://kalimbojp.exblog.jp |
Stay up to date on these results:
- Create an email alert for RTL1000
- Add a blog search gadget for RTL1000 to your Google homepage
- Subscribe to a blog search feed for RTL1000 in Google Reader New!
| Result Page: |  |  1 |  2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |  Next |
posted by Bill at 1:19 PM
0 Comments:
Post a Comment
<< Home